Insurance shares surged following Pfizer's announcement that it had developed, together with German biotech firm BioNTech, a COVID-19 vaccine that was more than 90% successful based on trials.
If you are already a subscriber
OR sign-up for a trial access here
Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.
more »
Brought to you by